Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 11/2021

01-11-2021 | Public Health | Original Article

Combined selective culture and molecular methods for the detection of carbapenem-resistant organisms from fecal specimens

Authors: Rebecca Yee, Stefanie Fisher, Yehudit Bergman, Krizia K. Chambers, Pranita D. Tamma, Karen C. Carroll, Patricia J. Simner

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 11/2021

Login to get access

Abstract

Detection of patients with intestinal colonization of carbapenem-resistant organisms (CRO), or more specifically carbapenemase-producing (CP) CRO, can prevent their transmission in healthcare facilities and aid with outbreak investigations. The objective of this work was to further develop and compare methods that combine selective culture and/or PCR to rapidly detect and recover CRO from fecal specimens. Molecularly characterized Gram-negative bacilli (n = 62) were used to spike fecal samples to establish limit of detection (LOD; n = 12), sensitivity (n = 28), and specificity (n= 21) for 3 methods to detect CP-CRO: direct MacConkey (MAC) plate and Xpert Carba-R (Cepheid) on growth, MAC broth and Carba-R testing of the broth, and direct testing by Carba-R. This was followed by a clinical study comparing methods in parallel for 286 fecal specimens. The LOD ranged from 102-105 CFU/mL depending on the carbapenemase gene and method. Combined culture/PCR methods had a sensitivity of 100%, whereas direct Carba-R testing had a sensitivity of 96% for the detection of CP-CRO. All methods had specificities of 100%. The prevalence of CP-CRO (0.7%) and non-CP-CRO (5.2 %) were low in the clinical study, where all methods demonstrated 100% agreement. The three methods performed comparably in detecting CP-CRO. Direct Carba-R testing had a higher LOD than the combined selective culture methods, but this may be offset by its rapid turnaround time for detection of CP-CRO. The selective culture methods provide the benefit of simultaneously isolating CP-CRO in culture for follow-up testing and detecting non-CP-CRO.
Appendix
Available only for authorised users
Literature
2.
go back to reference Bush K, Bradford PA (2020) Epidemiology of beta-Lactamase-Producing Pathogens. Clin Microbiol Rev 33(2):e00047–e00019CrossRef Bush K, Bradford PA (2020) Epidemiology of beta-Lactamase-Producing Pathogens. Clin Microbiol Rev 33(2):e00047–e00019CrossRef
3.
go back to reference Tamma PD, Kazmi A, Bergman Y, Goodman KE, Ekunseitan E, Amoah J, Simner PJ (2019) The likelihood of developing a carbapenem-resistant Enterobacteriaceae infection during a hospital stay. Antimicrob Agents Chemother 63(8):e00757–e00719CrossRef Tamma PD, Kazmi A, Bergman Y, Goodman KE, Ekunseitan E, Amoah J, Simner PJ (2019) The likelihood of developing a carbapenem-resistant Enterobacteriaceae infection during a hospital stay. Antimicrob Agents Chemother 63(8):e00757–e00719CrossRef
4.
go back to reference CDC. 2015. Facility guidance for control of carbapenem-resistant Enterobacteriaceae (CRE). November 2015 Update - CRE Tookit CDC. 2015. Facility guidance for control of carbapenem-resistant Enterobacteriaceae (CRE). November 2015 Update - CRE Tookit
5.
go back to reference Solter E, Adler A, Rubinovitch B, Temkin E, Schwartz D, Ben-David D, Masarwa S, Carmeli Y, Schwaber MJ (2018) Israeli national policy for carbapenem-resistant Enterobacteriaceae screening, carrier isolation and discontinuation of isolation. Infect Control Hosp Epidemiol 39:85–89CrossRef Solter E, Adler A, Rubinovitch B, Temkin E, Schwartz D, Ben-David D, Masarwa S, Carmeli Y, Schwaber MJ (2018) Israeli national policy for carbapenem-resistant Enterobacteriaceae screening, carrier isolation and discontinuation of isolation. Infect Control Hosp Epidemiol 39:85–89CrossRef
6.
go back to reference Moore NM, Canton R, Carretto E, Peterson LR, Sautter RL, Traczewski MM, Carba RST (2017) Rapid identification of five classes of carbapenem resistance genes directly from rectal swabs by use of the Xpert Carba-R assay. J Clin Microbiol 55:2268–2275CrossRef Moore NM, Canton R, Carretto E, Peterson LR, Sautter RL, Traczewski MM, Carba RST (2017) Rapid identification of five classes of carbapenem resistance genes directly from rectal swabs by use of the Xpert Carba-R assay. J Clin Microbiol 55:2268–2275CrossRef
7.
go back to reference Simner PJ, Martin I, Opene B, Tamma PD, Carroll KC, Milstone AM (2016) Evaluation of multiple methods for detection of gastrointestinal colonization of carbapenem-resistant organisms from rectal swabs. J Clin Microbiol 54:1664–1667CrossRef Simner PJ, Martin I, Opene B, Tamma PD, Carroll KC, Milstone AM (2016) Evaluation of multiple methods for detection of gastrointestinal colonization of carbapenem-resistant organisms from rectal swabs. J Clin Microbiol 54:1664–1667CrossRef
8.
go back to reference Workneh M, Wang R, Kazmi AQ, Chambers KK, Opene BNA, Lewis S, Goodman K, Tamma PD, Carroll KC, Milstone AM, Simner PJ (2019) Evaluation of the direct MacConkey method for identification of carbapenem-resistant gram-negative organisms from rectal swabs: re-evaluating zone diameter cutoffs. J Clin Microbiol 57(12):e01127–e01119CrossRef Workneh M, Wang R, Kazmi AQ, Chambers KK, Opene BNA, Lewis S, Goodman K, Tamma PD, Carroll KC, Milstone AM, Simner PJ (2019) Evaluation of the direct MacConkey method for identification of carbapenem-resistant gram-negative organisms from rectal swabs: re-evaluating zone diameter cutoffs. J Clin Microbiol 57(12):e01127–e01119CrossRef
10.
go back to reference Institute CaLS. 2020. Performance standards for antimicrobial susceptibility testing; Thirtieth Informational Supplement. Institute CaLS. 2020. Performance standards for antimicrobial susceptibility testing; Thirtieth Informational Supplement.
11.
go back to reference Pierce VM, Simner PJ, Lonsway DR, Roe-Carpenter DE, Johnson JK, Brasso WB, Bobenchik AM, Lockett ZC, Charnot-Katsikas A, Ferraro MJ, Thomson RB Jr, Jenkins SG, Limbago BM, Das S (2017) The modified carbapenem inactivation method (mCIM) for phenotypic detection of carbapenemase production among Enterobacteriaceae. J Clin Microbiol. https://doi.org/10.1128/JCM.00193-17 Pierce VM, Simner PJ, Lonsway DR, Roe-Carpenter DE, Johnson JK, Brasso WB, Bobenchik AM, Lockett ZC, Charnot-Katsikas A, Ferraro MJ, Thomson RB Jr, Jenkins SG, Limbago BM, Das S (2017) The modified carbapenem inactivation method (mCIM) for phenotypic detection of carbapenemase production among Enterobacteriaceae. J Clin Microbiol. https://​doi.​org/​10.​1128/​JCM.​00193-17
12.
go back to reference Simner PJ, Johnson JK, Brasso WB, Anderson K, Lonsway DR, Pierce VM, Bobenchik AM, Lockett ZC, Charnot-Katsikas A, Westblade LF, Yoo BB, Jenkins SG, Limbago BM, Das S, Roe-Carpenter DE (2018) Multicenter evaluation of the modified carbapenem inactivation method and the Carba NP for detection of carbapenemase-producing Pseudomonas aeruginosa and Acinetobacter baumannii. J Clin Microbiol 56(1):e01369–e01317CrossRef Simner PJ, Johnson JK, Brasso WB, Anderson K, Lonsway DR, Pierce VM, Bobenchik AM, Lockett ZC, Charnot-Katsikas A, Westblade LF, Yoo BB, Jenkins SG, Limbago BM, Das S, Roe-Carpenter DE (2018) Multicenter evaluation of the modified carbapenem inactivation method and the Carba NP for detection of carbapenemase-producing Pseudomonas aeruginosa and Acinetobacter baumannii. J Clin Microbiol 56(1):e01369–e01317CrossRef
13.
go back to reference Lau AF, Wang H, Weingarten RA, Drake SK, Suffredini AF, Garfield MK, Chen Y, Gucek M, Youn JH, Stock F, Tso H, DeLeo J, Cimino JJ, Frank KM, Dekker JP (2014) A rapid matrix-assisted laser desorption ionization-time of flight mass spectrometry-based method for single-plasmid tracking in an outbreak of carbapenem-resistant Enterobacteriaceae. J Clin Microbiol 52:2804–2812CrossRef Lau AF, Wang H, Weingarten RA, Drake SK, Suffredini AF, Garfield MK, Chen Y, Gucek M, Youn JH, Stock F, Tso H, DeLeo J, Cimino JJ, Frank KM, Dekker JP (2014) A rapid matrix-assisted laser desorption ionization-time of flight mass spectrometry-based method for single-plasmid tracking in an outbreak of carbapenem-resistant Enterobacteriaceae. J Clin Microbiol 52:2804–2812CrossRef
14.
go back to reference Simner PJ, Gilmour MW, DeGagne P, Nichol K, Karlowsky JA (2015) Evaluation of five chromogenic agar media and the Rosco Rapid Carb screen kit for detection and confirmation of carbapenemase production in Gram-negative bacilli. J Clin Microbiol 53:105–112CrossRef Simner PJ, Gilmour MW, DeGagne P, Nichol K, Karlowsky JA (2015) Evaluation of five chromogenic agar media and the Rosco Rapid Carb screen kit for detection and confirmation of carbapenemase production in Gram-negative bacilli. J Clin Microbiol 53:105–112CrossRef
15.
go back to reference Viau R, Frank KM, Jacobs MR, Wilson B, Kaye K, Donskey CJ, Perez F, Endimiani A, Bonomo RA (2016) Intestinal carriage of carbapenemase-producing organisms: current status of surveillance methods. Clin Microbiol Rev 29:1–27CrossRef Viau R, Frank KM, Jacobs MR, Wilson B, Kaye K, Donskey CJ, Perez F, Endimiani A, Bonomo RA (2016) Intestinal carriage of carbapenemase-producing organisms: current status of surveillance methods. Clin Microbiol Rev 29:1–27CrossRef
16.
go back to reference Karlowsky JA, Lob SH, Kazmierczak KM, Badal RE, Young K, Motyl MR, Sahm DF (2017) In vitro activity of imipenem against carbapenemase-positive Enterobacteriaceae isolates collected by the SMART Global Surveillance Program from 2008 to 2014. J Clin Microbiol 55:1638–1649CrossRef Karlowsky JA, Lob SH, Kazmierczak KM, Badal RE, Young K, Motyl MR, Sahm DF (2017) In vitro activity of imipenem against carbapenemase-positive Enterobacteriaceae isolates collected by the SMART Global Surveillance Program from 2008 to 2014. J Clin Microbiol 55:1638–1649CrossRef
17.
go back to reference Tato M, Ruiz-Garbajosa P, Traczewski M, Dodgson A, McEwan A, Humphries R, Hindler J, Veltman J, Wang H, Canton R (2016) Multisite evaluation of Cepheid Xpert Carba-R assay for detection of carbapenemase-producing organisms in rectal swabs. J Clin Microbiol 54:1814–1819CrossRef Tato M, Ruiz-Garbajosa P, Traczewski M, Dodgson A, McEwan A, Humphries R, Hindler J, Veltman J, Wang H, Canton R (2016) Multisite evaluation of Cepheid Xpert Carba-R assay for detection of carbapenemase-producing organisms in rectal swabs. J Clin Microbiol 54:1814–1819CrossRef
18.
go back to reference Workneh M, Wang R, Kazmi AQ, Chambers KK, Opene BNA, Lewis S, Goodman K, Tamma PD, Carroll KC, Milstone AM, Simner PJ (2019) Evaluation of the direct MacConkey method for identification of carbapenem-resistant gram-negative organisms from rectal swabs: reevaluating zone diameter cutoffs. J Clin Microbiol 57(12):e01127–e01119CrossRef Workneh M, Wang R, Kazmi AQ, Chambers KK, Opene BNA, Lewis S, Goodman K, Tamma PD, Carroll KC, Milstone AM, Simner PJ (2019) Evaluation of the direct MacConkey method for identification of carbapenem-resistant gram-negative organisms from rectal swabs: reevaluating zone diameter cutoffs. J Clin Microbiol 57(12):e01127–e01119CrossRef
Metadata
Title
Combined selective culture and molecular methods for the detection of carbapenem-resistant organisms from fecal specimens
Authors
Rebecca Yee
Stefanie Fisher
Yehudit Bergman
Krizia K. Chambers
Pranita D. Tamma
Karen C. Carroll
Patricia J. Simner
Publication date
01-11-2021
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 11/2021
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-021-04281-8

Other articles of this Issue 11/2021

European Journal of Clinical Microbiology & Infectious Diseases 11/2021 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.